Riskpilot← Back to searchSign inGet full accessLUNATUM AS
ASActiveOrg 911731274Greveveien 75, 0891 OsloPhysiotherapy activities · NACE 8695Est. 20131 employees
Revenue 2025
NOK 4,3M
+10% vs 2024
EBITDA margin
61.8%
+15% vs 2024
Equity ratio
3.9%
Financial strength
Net profit 2025
NOK 2,1M
+11% vs 2024
| Revenue | NOK 4,3M | +10% |
| EBITDA | NOK 2,6M | +15% |
| Net profit | NOK 2,1M | +11% |
| Total assets | NOK 3,2M | +5% |
| Equity | NOK 124K | -60% |
| Employees | 1 | — |
Legal name
LUNATUM AS
Org number
911731274
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
21. mars 2013
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Fysioterapi samt tilhørende helsetjenester. Selskapet vil også kunne investere i andre selskaper og eiendom.
Address
Greveveien 75, 0891 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 270 | 2 791 | 3 677 | 3 891 | 4 271 |
| Staff expenses | −958 | −870 | −814 | −993 | −982 |
| EBITDA | 1 609 | 1 415 | 2 281 | 2 303 | 2 639 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 609 | 1 415 | 2 281 | 2 303 | 2 639 |
| Net financials | 134 | 36 | 124 | 133 | 69 |
| Profit before tax | 1 743 | 1 451 | 2 404 | 2 435 | 2 708 |
| Tax | 357 | 329 | −0 | 537 | 596 |
| Net profit | 1 386 | 1 122 | 1 874 | 1 899 | 2 112 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 065 | 3 042 | 4 627 | 3 022 | 3 161 |
| Equity | 3 518 | 2 540 | 3 913 | 312 | 124 |
| Long-term debt | 0 | 6 | 7 | 0 | 0 |
| Short-term debt | 547 | 496 | 706 | 2 710 | 3 037 |
| Total debt | 547 | 503 | 713 | 2 710 | 3 037 |
EBITDA margin
61.8%
This company
15.8%
Market median
+291% vs market
20212025
Equity ratio
3.9%
This company
38.2%
Market median
-90% vs market
20212025
Return on equity
1701.4%
This company
18.4%
Market median
+9147% vs market
20212025
Net profit margin
49.5%
This company
8.1%
Market median
+511% vs market
20212025
Asset turnover
1.35×
This company
1.12×
Market median
+21% vs market
20212025
Debt / equity
24.46×
This company
0.62×
Market median
-3845% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SA Deputy Member | Deputy Member | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2016 | |
| Chairman | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LUNATUM AS 
ULLEVÅL OG TÅSEN FYSIOTERAPI OG TRENING ASBoard members of LUNATUM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Synne Amalie Grøttum Kolsvik | Deputy Member | 0 companies |
| Asgjerd Haukvik Grøttum | Board of Directors | 0 companies |
| Bård Magne Grøttum | Chairman | 0 companies |